Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients

Biological Psychiatry

Volumn 45, Issue 11, 1999, Pages 1433-1439

  Mück Šeler, Dorotea ^a,c   Pivac, Nela ^a,c   Jakovljević, Miro ^b,c   Brzović, Zdravko ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Dexamethasone suppression test; Plasma cortisol; Platelet serotonin; Schizophrenia

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; SEROTONIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; THROMBOCYTE RELEASE REACTION;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SCHIZOPHRENIA; SEROTONIN;

EID: 0345466578     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00174-7     Document Type: Article

References (41)

1. Abi-Dargham A., Laruelle M., Aghajanian G.K., Charney D., Krystal J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci. 9:1997;1-17.
2. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. 1987;American Psychiatric Press, Washington, DC.
3. 2 receptor binding properties and their regulation by endogenous serotonin. Life Sci. 52:1993;313-321.
4. Arora R.C., Meltzer H.Y. Serotonin uptake by blood platelets of schizophrenic patients. Psychiatry Res. 6:1982;327-333.
5. Baumgartner A., Gräf K.J., Kürten I. The dexamethasone suppression test in depression, in schizophrenia, and during experimental stress. Biol Psychiatry. 20:1985;675-679.
6. Baumgartner A., Gräf K.J., Kürten I. Serial dexamethasone suppression test in psychiatric illness Part I. A study in schizophrenia and mania . Psychiatry Res. 18:1986;9-23.
7. Baumgartner A., Haack D., Vecsei P. Serial dexamethasone suppression test in psychiatric illness Part III. The influence of intervening variables . Psychiatry Res. 18:1986;45-64.
8. Brady L.S., Whitfield H.J., Fox R.J., Gold P.W., Herkenham M. Long-term antidepressant administration alters corticotrophin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest. 87:1991;831-837.
9. Bräuning P., Rao M.L., Fimmers R. Blood serotonin levels in suicidal schizophrenic patients. Acta Psychiatr Scand. 79:1989;186-189.
10. Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res. 14:1995;187-202.
11. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., et al. A specific laboratory test for the diagnosis of melancholia Standardization, validation and clinical utility . Arch Gen Psychiatry. 38:1981;15-22.
12. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev. 18:1993;1-32.
13. DeLisi L.E., Neckers L.M., Weinberger D.R., Wyatt R.J. Increased whole blood serotonin concentrations in chronic schizophrenic patients. Arch Gen Psychiatry. 38:1981;647-650.
14. Dewan M.J., Pandurangi A.K., Levy B.F., Boucher M.L., Major L.F. Are schizophrenics with abnormal dexamethasone suppression test results a distinct subgroup? Acta Psychiatr Scand. 72:1985;274-277.
15. Dinan T.G. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci. 58:1996;1683-1694.
16. Flaum M., Swavze V.W., Oleary D.S., Yuh W.T.C., Ehrhardt J.C., Arndt S.V., et al. Effect of diagnosis, laterality and gender on brain morphology in schizophrenia. Am J Psychiatry. 152:1995;704-714.
17. Iqbal N., van Praag H.M. The role of serotonin in schizophrenia. Eur Neuropsychopharmacol. 5:(Suppl S):1995;11-23.
18. Jackman H., Luchins D., Meltzer H.Y. Platelet serotonin levels in schizophrenia Relationship to race and psychopathology . Biol Psychiatry. 18:1983;887-902.
19. Jakovljević M., Mück-Šeler D., Kenfelj H., Plavšić V., Biočina S., Kastratović D., et al. Basal cortisol, dexamethasone suppression test and platelet 5-HT in recurrent (unipolar) major depression, schizophrenia and schizoaffective disorder. Psychiatr Danubina. 3:1991;389-414.
20. Jakovljević M., Mück-Šeler D., Pivac N., Ljubičić D., Bujas M., Dodig G. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia. Biol Psychiatry. 41:1997;1028-1034.
21. Kaneko M., Murata S., Hoshino Y., Takahagi K., Yokoyama F., Watanabe M., et al. Dexamethasone suppression test in schizophrenia Its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis . Neuropsychiobiology. 24:1990;12-16.
22. Keitner G.I., Ryan C.E., Kohn R., Miller I.W., Norman W.H., Brown W.A. Age and the dexamethasone suppression test Results from a broad unselected patients population . Psychiatry Res. 44:1992;9-20.
23. Kendler K.S. Phenomenology of schizophrenia. Drug Dev Res. 9:1986;3-8.
24. Kolakowska T., Molyneux S.G. Platelet serotonin concentration in schizophrenic patients. Am J Psychiatry. 144:1987;232-234.
25. Lammers C.H., Garcia-Borreguero D., Schmider J., Gotthard U., Dettling M., Holsboer F., et al. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls II . Biol Psychiatry. 38:1995;803-807.
26. Lee P.H., Chan M.Y. Changes induced by corticosterone and adrenalectomy in synaptosomal and platelet uptake and binding of 5-HT. Neuropharmacology. 24:1985;1043-1050.
27. Lowry O.H., Rosenbrough N.S., Farr A.C., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
28. Maes M., Ruyter M., Claes R., Suy E. Sex-related differences in the relationships between self-rated depression and biological markers. J Affect Disord. 15:1988;119-125.
29. Mück-Šeler D., Jakovljević M., Deanović Ž. Time course of schizophrenia and platelet 5-HT. Biol Psychiatry. 23:1988;243-251.
30. Mück-Šeler D., Jakovljević M., Deanović Ž. Platelet serotonin in subtypes of schizophrenia and unipolar depression. Psychiatry Res. 38:1991;105-113.
31. Mück-Šeler D., Bujas M., Ljubić-Thibal V., Jakovljević M. Effect of age on platelet 5-HT concentrations in healthy controls, depressed and schizophrenic patients. Neuropsychobiology. 34:1996;201-203.
32. Owens M.J., Ballanger C.A., Knight D.L., Nemeroff C.B. Platelet 5-HT transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat. J Pharmacol Exp Ther. 278:1996;1040-1049.
33. Peiffer A., Veilleux S., Barden N. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology. 16:1991;505-515.
34. Pivac N., Mück-Šeler D., Jakovljević M. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms. Neuropsychobiology. 36:1997;19-21.
35. Roth B.L., Meltzer H.Y. The role of serotonin in schizophrenia. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;1215-1227 Raven Press, New York.
36. Slotkin T.A., McCook E.C., Ritchie J.C., Carroll B.J., Seidler F.J. Serotonin transporter expression in rat brain regions and blood platelets - aging and glucocorticoid effects. Biol Psychiatry. 41:1997;172-183.
37. Sora I., Nishimon K., Otsuki S. Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders. Biol Psychiatry. 21:1986;621-631.
38. Stahl S.M. Platelets as pharmacological models for the receptors and biochemistry of monoaminergic neurons. Longenecker G.L. Platelets Physiology and Pharmacology . 1985;307-340 Academic Press, New York.
39. Stokes P.E. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol. 5:(Suppl S):1995;77-82.
40. Tandon R., Silk K.R., Greder J.F., Goodson J., Hariharan M., Meador-Woodruff J.H., et al. Positive and negative symptoms in schizophrenia and the dexamethasone suppression test. Biol Psychiatry. 25:1989;785-788.
41. Tandon R., Mazzara C., DeQuardo J., Craig K.A., Meador-Woodruff J.H., Goldman R., et al. Dexamethasone suppression test in schizophrenia Relationship to symptomatology, ventricular enlargement and outcome . Biol Psychiatry. 29:1991;953-964.